Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denardo

Showing results (61-70 of 662) with videos related to

Pageof 67
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1986
Comparison of low- and medium-energy collimators for SPECT imaging with iodine-123-labeled antibodiesD J Macey, G L DeNardo, S J DeNardo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 1999
Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemiaG L DeNardo, S J DeNardo, S Shen, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 11, 2005
A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter wordsG R Mirick, B M Bradt, S J Denardo, et al.
American Journal of Surgery|August 1, 1977
Detection of anticoagulation therapy failures in patients with venous thrombosisE W Pollak, S DeNardo, M Pollak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Documentation of idiotypic cascade after Lym-1 radioimmunotherapy in a patient with non-Hodgkin's lymphoma: basis for extended survival?Bonnie M Bradt, Sally J DeNardo, Gary R Mirick, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
A revolution in the treatment of non-Hodgkin's lymphomaG L DeNardo, R T O'Donnell, R K Oldham, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2003
Human antiglobulin response to foreign antibodies: therapeutic benefit?Gerald L DeNardo, Bonnie M Bradt, Gary R Mirick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Direct antilymphoma effects on human lymphoma cells of monotherapy and combination therapy with CD20 and HLA-DR antibodies and 90Y-labeled HLA-DR antibodiesGerald L DeNardo, Evan Tobin, Kaylund Chan, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 27, 2008
Development of multivalent radioimmunonanoparticles for cancer imaging and therapyArutselvan Natarajan, Cheng-Yi Xiong, Cordula Gruettner, et al.
Leukemia & Lymphoma|May 10, 2007
Combination immunotherapy with anti-CD20 and anti-HLA-DR monoclonal antibodies induces synergistic anti-lymphoma effects in human lymphoma cell linesEvan Tobin, Gerald Denardo, Nan Zhang, et al.
Pageof 67

Showing results (61-70 of 662) with videos related to

Sort By:
Pageof 67
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1986
Comparison of low- and medium-energy collimators for SPECT imaging with iodine-123-labeled antibodiesD J Macey, G L DeNardo, S J DeNardo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 1999
Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemiaG L DeNardo, S J DeNardo, S Shen, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 11, 2005
A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter wordsG R Mirick, B M Bradt, S J Denardo, et al.
American Journal of Surgery|August 1, 1977
Detection of anticoagulation therapy failures in patients with venous thrombosisE W Pollak, S DeNardo, M Pollak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Documentation of idiotypic cascade after Lym-1 radioimmunotherapy in a patient with non-Hodgkin's lymphoma: basis for extended survival?Bonnie M Bradt, Sally J DeNardo, Gary R Mirick, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
A revolution in the treatment of non-Hodgkin's lymphomaG L DeNardo, R T O'Donnell, R K Oldham, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2003
Human antiglobulin response to foreign antibodies: therapeutic benefit?Gerald L DeNardo, Bonnie M Bradt, Gary R Mirick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Direct antilymphoma effects on human lymphoma cells of monotherapy and combination therapy with CD20 and HLA-DR antibodies and 90Y-labeled HLA-DR antibodiesGerald L DeNardo, Evan Tobin, Kaylund Chan, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 27, 2008
Development of multivalent radioimmunonanoparticles for cancer imaging and therapyArutselvan Natarajan, Cheng-Yi Xiong, Cordula Gruettner, et al.
Leukemia & Lymphoma|May 10, 2007
Combination immunotherapy with anti-CD20 and anti-HLA-DR monoclonal antibodies induces synergistic anti-lymphoma effects in human lymphoma cell linesEvan Tobin, Gerald Denardo, Nan Zhang, et al.
Pageof 67